Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Pillet

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Molecular Genetics & Genomic Medicine|April 1, 2017
Clinical dose effect and functional consequences of R92Q in two families presenting with a TRAPS/PFAPA-like phenotypeSylvie Grandemange, Sébastien Cabasson, Guillaume Sarrabay, et al.
Rheumatology (Oxford, England)|March 4, 2020
Validation of the new classification criteria for hereditary recurrent fever in an independent cohort: experience from the JIR Cohort DatabaseGlory Dingulu, Sophie Georgin-Lavialle, Isabelle Koné-Paut, et al.
Frontiers in Pharmacology|January 28, 2021
Long-Term Follow-Up and Optimization of Interleukin-1 Inhibitors in the Management of Monogenic Autoinflammatory Diseases: Real-Life Data from the JIR CohortVéronique Hentgen, Isabelle Koné-Paut, Alexandre Belot, et al.
Pediatric Rheumatology Online Journal|March 11, 2025
Minor salivary gland biopsy in the diagnosis of definite ocular sarcoidosis in paediatric granulomatous uveitisLeire Etchandy, Marie-Noelle Meaux, Olivier Richer, et al.
Pediatric Rheumatology Online Journal|September 4, 2021
Immunomodulatory treatment and surgical management of idiopathic uveitis and juvenile idiopathic arthritis-associated uveitis in children: a French survey practiceJulie Molimard, Christine Pajot, Priscille Olle, et al.
Medecine Sciences : M/S|September 12, 2022
[The transitional care from pediatrics to adult medicine within the rare autoimmune and autoinflammatory diseases network]Muriel Herasse, Mélanie Romier, Véronique Hentgen, et al.
The Journal of Allergy and Clinical Immunology|January 22, 2019
Novel proteasome assembly chaperone mutations in PSMG2/PAC2 cause the autoinflammatory interferonopathy CANDLE/PRAAS4Adriana A de Jesus, Anja Brehm, Rachel VanTries, et al.
Frontiers in Immunology|December 3, 2021
Real-Life Indications of Interleukin-1 Blocking Agents in Hereditary Recurrent Fevers: Data From the JIRcohort and a Literature ReviewCaroline Vinit, Sophie Georgin-Lavialle, Aikaterini Theodoropoulou, et al.
Joint Bone Spine|August 2, 2019
Infectious adverse events in children with Juvenile Idiopathic Arthritis treated with Biological Agents in a real-life setting: Data from the JIRcohorteCécile Dumaine, Sara Bekkar, Alexandre Belot, et al.
Frontiers in Medicine|December 6, 2021
Juvenile Idiopathic Arthritis and COVID-19 Pandemic: Good Compliance With Treatment, Reluctance to Return to SchoolBaptiste Quéré, Irene Lemelle, Anne Lohse, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Molecular Genetics & Genomic Medicine|April 1, 2017
Clinical dose effect and functional consequences of R92Q in two families presenting with a TRAPS/PFAPA-like phenotypeSylvie Grandemange, Sébastien Cabasson, Guillaume Sarrabay, et al.
Rheumatology (Oxford, England)|March 4, 2020
Validation of the new classification criteria for hereditary recurrent fever in an independent cohort: experience from the JIR Cohort DatabaseGlory Dingulu, Sophie Georgin-Lavialle, Isabelle Koné-Paut, et al.
Frontiers in Pharmacology|January 28, 2021
Long-Term Follow-Up and Optimization of Interleukin-1 Inhibitors in the Management of Monogenic Autoinflammatory Diseases: Real-Life Data from the JIR CohortVéronique Hentgen, Isabelle Koné-Paut, Alexandre Belot, et al.
Pediatric Rheumatology Online Journal|March 11, 2025
Minor salivary gland biopsy in the diagnosis of definite ocular sarcoidosis in paediatric granulomatous uveitisLeire Etchandy, Marie-Noelle Meaux, Olivier Richer, et al.
Pediatric Rheumatology Online Journal|September 4, 2021
Immunomodulatory treatment and surgical management of idiopathic uveitis and juvenile idiopathic arthritis-associated uveitis in children: a French survey practiceJulie Molimard, Christine Pajot, Priscille Olle, et al.
Medecine Sciences : M/S|September 12, 2022
[The transitional care from pediatrics to adult medicine within the rare autoimmune and autoinflammatory diseases network]Muriel Herasse, Mélanie Romier, Véronique Hentgen, et al.
The Journal of Allergy and Clinical Immunology|January 22, 2019
Novel proteasome assembly chaperone mutations in PSMG2/PAC2 cause the autoinflammatory interferonopathy CANDLE/PRAAS4Adriana A de Jesus, Anja Brehm, Rachel VanTries, et al.
Frontiers in Immunology|December 3, 2021
Real-Life Indications of Interleukin-1 Blocking Agents in Hereditary Recurrent Fevers: Data From the JIRcohort and a Literature ReviewCaroline Vinit, Sophie Georgin-Lavialle, Aikaterini Theodoropoulou, et al.
Joint Bone Spine|August 2, 2019
Infectious adverse events in children with Juvenile Idiopathic Arthritis treated with Biological Agents in a real-life setting: Data from the JIRcohorteCécile Dumaine, Sara Bekkar, Alexandre Belot, et al.
Frontiers in Medicine|December 6, 2021
Juvenile Idiopathic Arthritis and COVID-19 Pandemic: Good Compliance With Treatment, Reluctance to Return to SchoolBaptiste Quéré, Irene Lemelle, Anne Lohse, et al.
Pageof 5